Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response

• Main Authors: Areti Tychala (Author), Georgios Meletis (Author), Eugenia Katsimpourlia (Author), Ioanna Gkeka (Author), Rodoula Dimitriadou (Author), Eleni Sidiropoulou (Author), Lemonia Skoura (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Vaccines against SARS-CoV-2 are known to be less immunogenic for some individuals, whereas others present notably high levels of antibody production. We assessed the cellular response to BNT162b2 among individuals with low post-vaccination antibody levels as well as in a small group of individuals w...